Hong Kong Luxury Stock News

Chanjet Information Technology (SEHK:1588) has kicked off FY 2025 with first half revenue of C¥483.1 million and basic EPS of C¥0.10, against a backdrop of trailing twelve month EPS of C¥0.26 on revenue of C¥1.1 billion and reported earnings growth of 143.8% year over year. The company has seen revenue move from C¥452.9 million in 1H 2024 to C¥506.4 million in 2H 2024 and C¥483.1 million in 1H 2025, while EPS shifted from a loss of C¥0.03 in 1H 2024 to C¥0.14 in 2H 2024 and C¥0.10 in the...

China Everbright (SEHK:165) opened FY 2025 with first half revenue of HK$1.9 billion and basic EPS of HK$0.24, setting a very different tone from the losses seen in the trailing twelve month figures that still show basic EPS at HK$1.19 in the red on HK$1.2 billion of revenue. Over the past year, the company has seen revenue range from a loss making HK$176.4 million in 1H 2024 to HK$1.9 billion in 1H 2025. Basic EPS has moved from HK$0.76 in the red in early 2024 to HK$0.24 in the black more...

Texhong International Group FY 2025 results: margins move up the agenda Texhong International Group (SEHK:2678) has reported FY 2025 first half revenue of about CNY 11.0b with basic EPS of CNY 0.46, backed by trailing 12 month revenue of roughly CNY 22.7b and EPS of CNY 0.99. Over the last year, the company has seen half yearly revenue move from CNY 11.2b in 1H 2024 to CNY 11.8b in 2H 2024 and CNY 11.0b in 1H 2025, while basic EPS shifted from CNY 0.30 to CNY 0.31 and then to CNY 0.46. This...

JS Global Lifestyle (SEHK:1691) has reported first half FY 2025 revenue of US$774.1 million, with a basic EPS loss of US$0.017 per share setting the tone for a results update that keeps profitability firmly in focus. Over the past three half year periods, the company has seen revenue move from US$743.0 million in 1H FY 2024 to US$850.6 million in 2H FY 2024 and now US$774.1 million in 1H FY 2025. EPS has swung from a profit of US$0.006 in 1H FY 2024 to losses of US$0.004 and US$0.017 per...

China Aerospace International Holdings (SEHK:31) has reported its FY 2025 first half results, with revenue of HK$2,023.4 million and a basic EPS loss of HK$0.0137, keeping the focus squarely on margins and profitability at a current share price of HK$0.48. Over the last three reported halves, revenue moved from HK$1,824.8 million in 1H FY 2024 to HK$2,016.7 million in 2H FY 2024 and HK$2,023.4 million in 1H FY 2025. Basic EPS losses over those periods were HK$0.0093, HK$0.0080 and HK$0.0137...

If you are wondering whether Samsonite Group at HK$15.11 is offering value right now, the recent share price path gives you a lot to think about. The stock has seen a 0.7% decline over the past 7 days, a 21.1% decline over 30 days and is down 24.4% year to date, with a 13.2% decline over the past year and a 31.5% decline over three years, while the five year return sits at 12.4%. Recent coverage around Samsonite has focused on its position as a global luggage brand and how investor sentiment...

Blue Moon Group Holdings (SEHK:6993) has opened FY 2025 with first half revenue of HK$3.0b and a basic EPS loss of HK$0.082, keeping the focus squarely on how quickly profitability can improve from here. Over recent periods the business has seen half year revenue move from HK$3,131.2m in 1H 2024 to HK$5,424.4m in 2H 2024 and HK$3,036.8m in 1H 2025. EPS shifted from a HK$0.120 loss in 1H 2024 to a HK$0.0159 loss in 2H 2024 and a HK$0.082 loss in the latest half. With earnings still in the red...

Hebei Yichen Industrial Group (SEHK:1596) has reported FY 2025 first half revenue of C¥477.1 million and basic EPS of C¥0.05, alongside trailing twelve month revenue of C¥1.7 billion and EPS of C¥0.32 that cap a return to profitability after earlier losses. Over the past three half year periods, revenue has ranged from C¥498.7 million in 2024 H1 to C¥592.0 million in 2024 H2 and C¥477.1 million in 2025 H1. Over the same periods, net income has moved from a loss of C¥42.2 million in 2024 H1 to...

Nanshan Aluminium International Holdings (SEHK:2610) has put up a solid set of FY 2025 numbers, with first half revenue of US$596.8 million and basic EPS of US$0.46 framing the latest performance. The company has seen first half revenue move from US$423.3 million and EPS of US$0.30 in FY 2024 to US$596.8 million and US$0.46 in FY 2025. This progression sets up a margin story that investors may track closely as profit levels and pricing power come under closer scrutiny. See our full analysis...

Voicecomm Technology (SEHK:2495) has reported its FY 2025 results with first half revenue of C¥478.67 million, basic EPS of C¥2.10 and net income excluding extra items of C¥74.72 million, while the trailing twelve months show revenue of C¥1.01 billion and EPS of C¥3.81 backed by C¥135.48 million of net income. Over recent periods the company has seen revenue range from C¥371.17 million to C¥570.24 million per half year. EPS has moved from a loss of C¥19.09 in 2024 H1 to positive C¥2.99 in...

Lianlian DigiTech (SEHK:2598) has just posted FY 2025 first half results with revenue of C¥782.7 million and basic EPS of C¥1.42, putting fresh numbers behind its recent move into profitability and a share price of C¥5.98. Over the last three reported half years, revenue has moved from C¥617.4 million in 1H 2024 to C¥697.6 million in 2H 2024 and now C¥782.7 million. Over the same periods, basic EPS shifted from a loss of C¥0.34 in 1H 2024 to C¥0.17 in 2H 2024 and C¥1.42 in 1H 2025. This sets...

Cloud Factory Technology Holdings (SEHK:2512) has reported its FY 2025 results with first half revenue of C¥406.8 million and basic EPS of C¥0.0319, setting the tone against a trailing twelve month picture that shows revenue of C¥943.5 million and EPS of C¥0.02. Over the last few reporting periods, revenue has moved from C¥369.7 million in 1H FY 2024 to C¥337.9 million in 2H FY 2024 and then to C¥406.8 million in 1H FY 2025, while basic EPS shifted from C¥0.0322 to a small loss of C¥0.0005...

Latest FY 2025 Results Set Up The Earnings Story Innovent Biologics (SEHK:1801) has just reported its FY 2025 numbers with second half revenue of about C¥7.1b and basic EPS of C¥0.01 loss per share, while on a trailing twelve month basis revenue sits at roughly C¥13.0b and basic EPS at C¥0.48. Over recent reporting halves the company has seen revenue move from C¥5.5b in 2H 2024 to C¥6.0b in 1H 2025 and then to C¥7.1b in 2H 2025, alongside basic EPS shifting from C¥0.18 in 2H 2024 to C¥0.51 in...

Yeahka (SEHK:9923) just released its FY 2025 first half numbers, with revenue of C¥1.6b, basic EPS of C¥0.11, and trailing 12 month EPS of C¥0.23 supported by net income of C¥92.2m. The company has seen revenue move from C¥1.58b in 1H 2024 to C¥1.51b in 2H 2024 and then to C¥1.64b in 1H 2025. Net income excluding extra items tracked from C¥31.6m to C¥50.8m to C¥43.1m over the same periods, setting up a results season where investors are watching how improving profit margins interact with the...

REPT BATTERO Energy (SEHK:666) has just posted its FY 2025 first half numbers, with revenue of C¥9.5b and a basic EPS loss of C¥0.03, alongside trailing twelve month revenue of C¥24.3b and EPS of C¥0.27 that reflects the recent move into profitability. The company has seen revenue step up from C¥7.6b in 2024 H1 to C¥9.5b in 2025 H1 and C¥10.2b in 2024 H2 on a reported basis. Basic EPS has moved from a loss of C¥0.19 in 2024 H1 and a loss of C¥0.32 in 2024 H2 to a smaller loss of C¥0.03 in the...

Yip's Chemical Holdings (SEHK:408) has reported its FY 2025 first half with revenue of HK$1,430.4 million and basic EPS of HK$0.12, set against a trailing twelve month net income of HK$137.4 million and EPS of HK$0.25, where earnings grew 41.8% over the past year. The company has seen revenue move from HK$1,557.4 million in 1H FY 2024 to HK$1,605.0 million in 2H FY 2024 and HK$1,430.4 million in 1H FY 2025, while net income excluding extra items went from HK$34.1 million to HK$62.8 million...

Hua Medicine (Shanghai) (SEHK:2552) has reported FY 2025 first half revenue of C¥217.4 million and basic EPS of C¥1.20, marking a clear break from the losses seen a year earlier when basic EPS was C¥0.15 and revenue was C¥102.7 million. Over the past three half year periods, revenue has moved from C¥102.7 million in 1H 2024 to C¥153.2 million in 2H 2024 and then to C¥217.4 million in 1H 2025. Over the same span, trailing twelve month basic EPS has shifted from a loss of C¥0.25 in 2H 2024 to a...

Liaoning Port (SEHK:2880) has posted its FY 2025 numbers with fourth quarter revenue of C¥2.9b and basic EPS of C¥0.000276, rounding out a trailing twelve month revenue base of C¥11.4b and EPS of C¥0.054807. Over recent quarters the company has seen revenue move from C¥3.1b in Q4 2024 to C¥2.9b in Q4 2025, while quarterly EPS shifted from C¥0.008271 to C¥0.000276. This sets a backdrop to the reported 14.2% earnings growth over the last year and an 11.5% trailing net margin versus 10.3% a year...

Peijia Medical (SEHK:9996) has reported FY 2025 first half results with revenue of C¥353.38 million and a basic EPS loss of C¥0.104926, alongside net income excluding extra items of a C¥69.88 million loss that keeps profitability in focus for investors. The company has seen revenue move from C¥301.20 million in 1H 2024 to C¥353.38 million in 1H 2025, while basic EPS stayed at roughly a C¥0.10 loss and trailing 12 month net income excluding extra items sits at a C¥203.29 million loss. The key...

Shanghai HeartCare Medical Technology (SEHK:6609) has just posted its FY 2025 results, with first half revenue at C¥185.5 million and basic EPS of C¥1.34, while trailing twelve month revenue sits at C¥408.3 million and EPS at C¥2.21 as the business turned profitable over the past year. The company has seen revenue move from C¥128.5 million in the first half of 2024 to C¥149.4 million in the second half of 2024 and then to C¥185.5 million in the first half of 2025. This has come alongside a...

Nissin Foods (SEHK:1475) has just wrapped up FY 2025 with fourth quarter revenue of HK$939 million and basic EPS of HK$0.07, alongside trailing twelve month revenue of HK$4.0 billion and EPS of HK$0.32 that reflect a 64.9% earnings increase over the last year. Over recent periods, revenue has ranged from HK$859 million in Q2 FY 2024 to HK$1.07 billion in Q1 FY 2025. Quarterly EPS has moved between HK$0.04 and HK$0.11, setting up a story where recent margin gains and an 8.3% net profit margin...

Excellence Commercial Property & Facilities Management Group (SEHK:6989) opened FY 2025 with first half revenue of C¥1,996.2 million and basic EPS of C¥0.12, setting the tone for another period where topline scale contrasts with tighter profitability. Over the last three reported halves, revenue has moved from C¥2,063.1 million in 1H 2024 to C¥2,149.8 million in 2H 2024 and C¥1,996.2 million in 1H 2025. Over the same period, basic EPS shifted from C¥0.14 to C¥0.12 and then C¥0.12 again,...

Mabpharm (SEHK:2181) has reported its FY 2025 first half results with revenue of C¥274.2 million and basic EPS of C¥0.000702, while trailing 12 month figures show revenue of C¥646.1 million and basic EPS of C¥0.01 as the business moves through its first year of profitability. Over the past reported periods, revenue has shifted from C¥108.5 million in 1H FY 2024 to C¥149.7 million in 2H FY 2024 and then to C¥274.2 million in 1H FY 2025, with net income moving from a loss of C¥97.6 million in...

Zhou Hei Ya International Holdings (SEHK:1458) has opened FY 2025 with first half revenue of C¥1.22b and basic EPS of C¥0.053, setting the tone against a trailing twelve month picture that shows revenue of C¥2.54b and basic EPS of about C¥0.08. Over recent periods the company has seen revenue move from C¥1.26b in 1H 2024 to C¥1.19b in 2H 2024 and C¥1.22b in 1H 2025. Over the same intervals, basic EPS shifted from C¥0.015 to C¥0.030 and then to C¥0.053, giving investors a fresh read on how...